Skip to main content
October 05, 2019
SAN DIEGO—People with binge eating disorder (BED) are at increased risk of suicidal ideation and suicide attempt—and that risk appears even greater if they also have attention-deficit/hyperactivity disorder (ADHD) or have had bariatric surgery.​​​​​​​
October 04, 2019
SAN DIEGO—Clinicians tend to decrease monotherapy and increase adjunctive therapy when patients with major depressive disorder experience major depressive episodes, according to research presented at Psych Congress 2019.
October 04, 2019
SAN DIEGO—When added to ongoing treatment, pimavanserin significantly improved sexual function in patients with major depressive disorder, according to study results shared during poster sessions at Psych Congress 2019.
October 04, 2019
SAN DIEGO—Added to standard-of-care treatment, esketamine nasal spray rapidly reduced depressive symptoms in patients at imminent risk of suicide, according to two phase 3 trials presented at Psych Congress 2019.
October 04, 2019
SAN DIEGO—Mindfulness meditation is an effective, evidence-based treatment which can improve symptoms of anxiety, depression, and other mental health conditions, two speakers told attendees at a Psych Congress 2019 session.
October 04, 2019
SAN DIEGO—Prescribers who may be seeing an increase in patients with stimulant use disorders are still left relying on off-label treatment options with limited evidence of effectiveness, a researcher told a Psych Congress audience.
October 04, 2019
SAN DIEGO—Combinatorial pharmacogenomic testing offers clinical utility for patients with major depressive disorder who have failed to respond to medication for genetic reasons, according to a study presented at Psych Congress 2019.
October 04, 2019
SAN DIEGO—Side effects were experienced nearly universally by respondents in an online survey who took oral antipsychotics the previous year for bipolar I disorder, according to results presented at a Psych Congress 2019 poster session.
October 04, 2019
SAN DIEGO—Just half of survey respondents who took oral antipsychotics for schizophrenia thought the medication did more good than harm, according to research presented during poster sessions at Psych Congress 2019.
October 04, 2019
SAN DIEGO—Major depressive disorder relapse is linked with higher health care utilization and costs, researchers reported during a poster session at Psych Congress 2019.
Back to Top